secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2024-02-01T23:59:59+00:00
Accession:  0001022079-24-000009
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics Q4 2023 adjusted EPS $2.15, +8.6%; base business revenue +4.7%
--------------------------------------------------------------------------------

- Q4 reported net revenue $2.29B (-1.9% YoY); base business revenue $2.25B (+4.7%).
- Q4 reported diluted EPS $1.70 (+95.4%); adjusted diluted EPS $2.15 (+8.6%).
- Full year 2023 base business revenue grew 7.1% to $9.03B; COVID testing fell 84.7% to $223M.
- Quarterly dividend raised 5.6% to $0.75; payable April 22, 2024 to record date April 8.
- FY2024 guidance: revenue $9.35-$9.45B; reported EPS $7.69-$7.99; adjusted EPS $8.60-$8.90.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000102207924000009/0001022079-24-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000102207924000009/dgx-20240201.htm
  HTML page:      https://secwatch.observer/filing/0001022079-24-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer